376 related articles for article (PubMed ID: 25606800)
1. Vascular endothelial growth factor c/vascular endothelial growth factor receptor 3 signaling regulates chemokine gradients and lymphocyte migration from tissues to lymphatics.
Iwami D; Brinkman CC; Bromberg JS
Transplantation; 2015 Apr; 99(4):668-77. PubMed ID: 25606800
[TBL] [Abstract][Full Text] [Related]
2. Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts.
Nykänen AI; Sandelin H; Krebs R; Keränen MA; Tuuminen R; Kärpänen T; Wu Y; Pytowski B; Koskinen PK; Ylä-Herttuala S; Alitalo K; Lemström KB
Circulation; 2010 Mar; 121(12):1413-22. PubMed ID: 20231530
[TBL] [Abstract][Full Text] [Related]
3. Lymphangiogenesis Facilitates Initial Lymph Formation and Enhances the Dendritic Cell Mobilizing Chemokine CCL21 Without Affecting Migration.
Karlsen TV; Reikvam T; Tofteberg A; Nikpey E; Skogstrand T; Wagner M; Tenstad O; Wiig H
Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2128-2135. PubMed ID: 28935759
[TBL] [Abstract][Full Text] [Related]
4. Shape and Function of Interstitial Chemokine CCL21 Gradients Are Independent of Heparan Sulfates Produced by Lymphatic Endothelium.
Vaahtomeri K; Moussion C; Hauschild R; Sixt M
Front Immunol; 2021; 12():630002. PubMed ID: 33717158
[TBL] [Abstract][Full Text] [Related]
5. Circadian clocks guide dendritic cells into skin lymphatics.
Holtkamp SJ; Ince LM; Barnoud C; Schmitt MT; Sinturel F; Pilorz V; Pick R; Jemelin S; Mühlstädt M; Boehncke WH; Weber J; Laubender D; Philippou-Massier J; Chen CS; Holtermann L; Vestweber D; Sperandio M; Schraml BU; Halin C; Dibner C; Oster H; Renkawitz J; Scheiermann C
Nat Immunol; 2021 Nov; 22(11):1375-1381. PubMed ID: 34663979
[TBL] [Abstract][Full Text] [Related]
6. Inflammation-induced secretion of CCL21 in lymphatic endothelium is a key regulator of integrin-mediated dendritic cell transmigration.
Johnson LA; Jackson DG
Int Immunol; 2010 Oct; 22(10):839-49. PubMed ID: 20739459
[TBL] [Abstract][Full Text] [Related]
7. Normal dendritic cell mobilization to lymph nodes under conditions of severe lymphatic hypoplasia.
Platt AM; Rutkowski JM; Martel C; Kuan EL; Ivanov S; Swartz MA; Randolph GJ
J Immunol; 2013 May; 190(9):4608-20. PubMed ID: 23530147
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype.
Issa A; Le TX; Shoushtari AN; Shields JD; Swartz MA
Cancer Res; 2009 Jan; 69(1):349-57. PubMed ID: 19118020
[TBL] [Abstract][Full Text] [Related]
9. A critical role for lymphatic endothelial heparan sulfate in lymph node metastasis.
Yin X; Truty J; Lawrence R; Johns SC; Srinivasan RS; Handel TM; Fuster MM
Mol Cancer; 2010 Dec; 9():316. PubMed ID: 21172016
[TBL] [Abstract][Full Text] [Related]
10. DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling.
Tal O; Lim HY; Gurevich I; Milo I; Shipony Z; Ng LG; Angeli V; Shakhar G
J Exp Med; 2011 Sep; 208(10):2141-53. PubMed ID: 21930767
[TBL] [Abstract][Full Text] [Related]
11. Intralymphatic CCL21 Promotes Tissue Egress of Dendritic Cells through Afferent Lymphatic Vessels.
Russo E; Teijeira A; Vaahtomeri K; Willrodt AH; Bloch JS; Nitschké M; Santambrogio L; Kerjaschki D; Sixt M; Halin C
Cell Rep; 2016 Feb; 14(7):1723-1734. PubMed ID: 26876174
[TBL] [Abstract][Full Text] [Related]
12. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
[TBL] [Abstract][Full Text] [Related]
13. Lymphatic vascular endothelial hyaluronan receptor (LYVE)-1- and CCL21-positive lymphatic compartments in the diabetic thymus.
Ji RC; Kurihara K; Kato S
Anat Sci Int; 2006 Dec; 81(4):201-9. PubMed ID: 17176958
[TBL] [Abstract][Full Text] [Related]
14. Lymphatic and Immune Cell Cross-Talk Regulates Cardiac Recovery After Experimental Myocardial Infarction.
Houssari M; Dumesnil A; Tardif V; Kivelä R; Pizzinat N; Boukhalfa I; Godefroy D; Schapman D; Hemanthakumar KA; Bizou M; Henry JP; Renet S; Riou G; Rondeaux J; Anouar Y; Adriouch S; Fraineau S; Alitalo K; Richard V; Mulder P; Brakenhielm E
Arterioscler Thromb Vasc Biol; 2020 Jul; 40(7):1722-1737. PubMed ID: 32404007
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19.
Haessler U; Pisano M; Wu M; Swartz MA
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5614-9. PubMed ID: 21422278
[TBL] [Abstract][Full Text] [Related]
16. Oncostatin M enhances CCL21 expression by microvascular endothelial cells and increases the efficiency of dendritic cell trafficking to lymph nodes.
Sugaya M; Fang L; Cardones AR; Kakinuma T; Jaber SH; Blauvelt A; Hwang ST
J Immunol; 2006 Dec; 177(11):7665-72. PubMed ID: 17114436
[TBL] [Abstract][Full Text] [Related]
17. Chronic inflammation, lymphangiogenesis, and effect of an anti-VEGFR therapy in a mouse model and in human patients with aspiration pneumonia.
Nihei M; Okazaki T; Ebihara S; Kobayashi M; Niu K; Gui P; Tamai T; Nukiwa T; Yamaya M; Kikuchi T; Nagatomi R; Ebihara T; Ichinose M
J Pathol; 2015 Mar; 235(4):632-45. PubMed ID: 25348279
[TBL] [Abstract][Full Text] [Related]
18. Blocking MAPK signaling downregulates CCL21 in lymphatic endothelial cells and impairs contact hypersensitivity responses.
Miyagaki T; Sugaya M; Okochi H; Asano Y; Tada Y; Kadono T; Blauvelt A; Tamaki K; Sato S
J Invest Dermatol; 2011 Sep; 131(9):1927-35. PubMed ID: 21593766
[TBL] [Abstract][Full Text] [Related]
19. Interstitial dendritic cell guidance by haptotactic chemokine gradients.
Weber M; Hauschild R; Schwarz J; Moussion C; de Vries I; Legler DF; Luther SA; Bollenbach T; Sixt M
Science; 2013 Jan; 339(6117):328-32. PubMed ID: 23329049
[TBL] [Abstract][Full Text] [Related]
20. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
